Attached files
file | filename |
---|---|
8-K - FORM 8-K - Isoray, Inc. | isr20210824_8k.htm |
Exhibit 10.1
Certain identified information has been excluded from this exhibit because it is both (i) not material and (ii) would be competitively harmful if publicly disclosed.
Addendum No. 2 dated 2021.08.16 to
Contract No. 840/08625142/31/22-21
Date of signature: 2021.03.18
THE SELLER
Isotope - Regional Alliance, Joint-Stock Company (Isotope JSC)
Pogodinskaya str., 22, Moscow, 119435, Russia.
Phone: +7(495) 981-96-16
THE BUYER
The Company Isoray Medical Inc.
350 Hills Street, Suite 106
Richland, WA 99354-5411 USA
THE BUYER and THE SELLERS have mutually agreed about the following:
The following company is determined by the Buyer as a Supplier of the Goods, produced by JSC "SSC RIAR": MedikorPharma-Ural LLC, 620109, Sverdlovskaya region, Yekaterinburg, Krulya Street, 2, apartment 192, Tel.: 8(343) 270-75-29, E-mail: dpbugaev@gmail.com. The Buyer is responsible to the Seller for MedikorPharma-Ural LLC fulfillment of its obligations. The cost of services, provided by MedikorPharma-Ural LLC, shall not exceed USD [**] [**].
The present addendum is the integral part of contract 840/08625142/31/22-21 and may be signed by E-mail.
All other terms and conditions are in accordance with Contract No. 840/08625142/31/22-21, Appendices 1 and 2, Addendum 1.
THE SELLER | THE BUYER | ||
/s/ Konstantin Ershov | /s/ Jonathan Hunt | ||
Konstantin Ershov | Jonathan Hunt | ||
19 Aug 2021 | 19 Aug 2021 | ||
Head of Sales Department, JSC Isotope | Isoray - CFO |